The UK’s Silence Therapeutics PLC and Alnylam Pharmaceuticals Inc. have agreed to settle litigation in which the former accused the latter of infringing its European patents.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?